Phase 1 Obesity Trial, Recruiting (NCT06502834)

Phase 1 Obesity Trial, Recruiting NCT06502834 Sponsor: Max Nieuwdorp Condition: Obesity

Printed from Voxsanity (voxsanity.com.au) — NCT06502834 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Obesity

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a man, or a woman who has been through menopause
You have a larger waist size (over 102 cm / about 40 inches for men, or over 88 cm / about 35 inches for women)
You have been found to have insulin resistance, meaning your body does not respond to insulin as well as it should (shown by a specific blood test result called HOMA above 2.5 — confirm with trial site)
You are between 18 and 70 years old

Who may not be able to join:

You have taken any regular prescription or over-the-counter medicines in the past three months or would need to during the study, with the exception of paracetamol (this includes antibiotics, probiotics, or prebiotics)
You have had a heart attack, stroke, or other serious heart or blood vessel event in the past
You have had your gallbladder removed
You have a known, untreated gut or digestive condition, or you have ongoing unusual changes in your bowel habits
Your liver function blood test results are significantly higher than the normal range (more than 2.5 times the upper limit)
You are a current smoker
You drink alcohol excessively

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Max Nieuwdorp, prof dr, Amsterdam UMC, location AMC

Phone: 020-5669111

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06502834

Sponsor: Max Nieuwdorp

Phase: Phase 1

Status: Recruiting

Condition: Obesity

Trial contact: 020-5669111

More information: https://clinicaltrials.gov/study/NCT06502834

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a man, or a woman who has been through menopause
You have a larger waist size (over 102 cm / about 40 inches for men, or over 88 cm / about 35 inches for women)
You have been found to have insulin resistance, meaning your body does not respond to insulin as well as it should (shown by a specific blood test result called HOMA above 2.5 — confirm with trial site)
You are between 18 and 70 years old

Who may not be able to join:

You have taken any regular prescription or over-the-counter medicines in the past three months or would need to during the study, with the exception of paracetamol (this includes antibiotics, probiotics, or prebiotics)
You have had a heart attack, stroke, or other serious heart or blood vessel event in the past
You have had your gallbladder removed
You have a known, untreated gut or digestive condition, or you have ongoing unusual changes in your bowel habits
Your liver function blood test results are significantly higher than the normal range (more than 2.5 times the upper limit)
You are a current smoker
You drink alcohol excessively

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 1

Sponsor

Max Nieuwdorp

Registry

ClinicalTrials.gov

Start date

1 May 2024

Est. completion

1 December 2024

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Gut engraftment; adverse events; Renal function; Occurence of anemia; Changes in leucocytes; Changes in thrombocytes; Changes in aspartate aminotransferase (AST); Changes in alanine aminotransferase (ALT); Changes in alkaline phosphatase (ALP); Changes in Gamma-glutamyltransferase (GGT); Changes in total bilirubin

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov